Targeting BRAF in thyroid cancer

por Espinosa, A V, Porchia, L, Ringel, M D
Publicado 2007

Liver cancer risk, coffee, and hepatitis C virus infection: a nested case–control study in Japan

por Wakai, K, Kurozawa, Y, Shibata, A, Fujita, Y, Kotani, K, Ogimoto, I, Naito, M, Nishio, K, Suzuki, H, Yoshimura, T, Tamakoshi, A
Publicado 2007

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

por Takigawa, N, Kiura, K, Segawa, Y, Watanabe, Y, Kamei, H, Moritaka, T, Shibayama, T, Ueoka, H, Gemba, K, Yonei, T, Tabata, M, Shinkai, T, Hiraki, S, Takemoto, M, Kanazawa, S, Matsuo, K, Tanimoto, M
Publicado 2006

Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001)

por Zorzi, M, Puliti, D, Vettorazzi, M, De Lisi, V, Falcini, F, Federico, M, Ferretti, S, Moffa, I F, Mangone, L, Mano, M P, Naldoni, C, Ponti, A, Traina, A, Tumino, R, Paci, E
Publicado 2006

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer

por Van den Eynden, G G, Van der Auwera, I, Van Laere, S J, Huygelen, V, Colpaert, C G, van Dam, P, Dirix, L Y, Vermeulen, P B, Van Marck, E A
Publicado 2006

Are microRNAs located in genomic regions associated with cancer?

por Lamy, P, Andersen, C L, Dyrskjot, L, Torring, N, Orntoft, T, Wiuf, C
Publicado 2006

A novel proteasome inhibitor NPI-0052 as an anticancer therapy

por Chauhan, D, Hideshima, T, Anderson, K C
Publicado 2006

Association of decreased mitochondrial DNA content with ovarian cancer progression

por Wang, Y, Liu, V W S, Xue, W C, Cheung, A N Y, Ngan, H Y S
Publicado 2006

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

por Van der Auwera, I, Cao, Y, Tille, J C, Pepper, M S, Jackson, D G, Fox, S B, Harris, A L, Dirix, L Y, Vermeulen, P B
Publicado 2006

A twist for survival and cancer progression

por Puisieux, A, Valsesia-Wittmann, S, Ansieau, S
Publicado 2006

Adrenomedullin and tumour angiogenesis

por Nikitenko, L L, Fox, S B, Kehoe, S, Rees, M C P, Bicknell, R
Publicado 2006

ARF-BP1 as a potential therapeutic target

por Chen, D, Brooks, C L, Gu, W
Publicado 2006

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

por Maisey, N R, Norman, A R, Hill, A, Massey, A, Oates, J, Cunningham, D
Publicado 2005

Systematic review of the relationship between family history and lung cancer risk

por Matakidou, A, Eisen, T, Houlston, R S
Publicado 2005

Meta-analysis of cancer incidence in children born after assisted reproductive technologies

por Raimondi, S, Pedotti, P, Taioli, E
Publicado 2005

Integrin β1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo

por Brockbank, E C, Bridges, J, Marshall, C J, Sahai, E
Publicado 2005

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

por Wachters, F M, Groen, H J M, Biesma, B, Schramel, F M N H, Postmus, P E, Stigt, J A, Smit, E F
Publicado 2005

Social and geographic disparities in access to reference care site for patients with colorectal cancer in France

por Dejardin, O, Bouvier, A-M, Herbert, C, Velten, M, Buemi, A, Delafosse, P, Maarouf, N, Boutreux, S, Launoy, G
Publicado 2005

The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva

por Narayansingh, G V, Miller, I D, Sharma, M, Welch, C J, Sharp, L, Parkin, D E, Cruickshank, M E
Publicado 2005

Role of survivin and its splice variants in tumorigenesis

por Li, F
Publicado 2005